NFE2L2 and Parkinson disease: Interestingly, a mutation in NFE2L2, that is thought to increase its transcriptional activity, was shown to decrease the risk of PD and delay its onset, suggesting that levels of NRF2 activity may be inversely correlated with PD susceptibility [185].